| Taizhou Crene Biotechnology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.pharm-intermediates.com | |||
![]() | +86 (576) 8881-3233 8820-5808 +86 13396860566 | |||
![]() | +86 (576) 8822-9589 | |||
![]() | sales@pharm-intermediates.com | |||
![]() | QQ Chat | |||
| Chemical manufacturer since 2011 | ||||
| chemBlink Standard supplier since 2009 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.bocsci.com | |||
![]() | +1 (631) 485-4226 | |||
![]() | +1 (631) 614-7828 | |||
![]() | info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| Amadis Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.amadischem.com | |||
![]() | +86 (571) 8992-5085 | |||
![]() | +86 (571) 8992-5065 | |||
![]() | sales@amadischem.com | |||
| Chemical manufacturer since 2010 | ||||
| chemBlink Standard supplier since 2015 | ||||
| Exclusive Chemistry Ltd. | Russia | Inquire | ||
|---|---|---|---|---|
![]() | www.exchemistry.com | |||
![]() | +7 (903) 713-5556 | |||
![]() | +7 (484) 396-4302 | |||
![]() | info@exchemistry.com | |||
| Chemical manufacturer | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.scbt.com | |||
![]() | +1 (831) 457-3800 | |||
![]() | +1 (831) 457-3801 | |||
![]() | scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Classification | Biochemical >> Inhibitor >> TGF-beta/Smad signaling pathway inhibitor (TGF-beta/Smad) >> TGF-beta/Smad inhibitor |
|---|---|
| Name | 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline |
| Synonyms | E 616451; HTS 466284; LY 364947 |
| Molecular Structure | ![]() |
| Molecular Formula | C17H12N4 |
| Molecular Weight | 272.30 |
| CAS Registry Number | 396129-53-6 |
| EC Number | 636-801-2 |
| Solubility | Practically insoluble (0.013 g/L) (25 °C), Calc.* |
|---|---|
| Density | 1.283±0.06 g/cm3 (20 °C 760 Torr), Calc.* |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2013 ACD/Labs) |
| Hazard Symbols | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R25;R36/37/38;R50/53 Details | ||||||||||||||||||||||||||||||||||||
| Safety Statements | S26;S45;S60;S61 Details | ||||||||||||||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| Transport Information | UN 2811 6.1/PG 3 | ||||||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for 4-[3-(2-Pyridinyl)-1H-pyrazol-4-yl]quinoline |